146 related articles for article (PubMed ID: 21914587)
1. Livedoid vasculopathy; favorable clinical response with low dose warfarin.
Nakamura S; Kishibe M; Nishi K; Hashimoto Y; Takeda K; Mizumoto T; Iizuka H
Eur J Dermatol; 2011; 21(6):1011-2. PubMed ID: 21914587
[No Abstract] [Full Text] [Related]
2. Case of livedoid vasculopathy with peripheral neuropathy successfully treated with low-dose warfarin.
Osada S; Kimura Y; Kawana S
J Dermatol; 2010 Jan; 37(1):98-101. PubMed ID: 20175830
[TBL] [Abstract][Full Text] [Related]
3. Livedoid vasculopathy in a patient with lupus anticoagulant and MTHFR mutation: treatment with low-molecular-weight heparin.
Abou Rahal J; Ishak RS; Otrock ZK; Kibbi AG; Taher AT
J Thromb Thrombolysis; 2012 Nov; 34(4):541-4. PubMed ID: 22592843
[TBL] [Abstract][Full Text] [Related]
4. Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin.
Davis MD; Wysokinski WE
J Am Acad Dermatol; 2008 Mar; 58(3):512-5. PubMed ID: 18280355
[TBL] [Abstract][Full Text] [Related]
5. A case of livedoid vasculopathy associated with factor V Leiden mutation: successful treatment with oral warfarin.
Kavala M; Kocaturk E; Zindanci I; Turkoglu Z; Altintas S
J Dermatolog Treat; 2008; 19(2):121-3. PubMed ID: 18484430
[TBL] [Abstract][Full Text] [Related]
6. Livedoid vasculopathy secondary to high levels of lipoprotein(a).
Vasconcelos R; Criado PR; Belda W
Br J Dermatol; 2011 May; 164(5):1111-3. PubMed ID: 21219292
[No Abstract] [Full Text] [Related]
7. Leg ulcers associated with factor V Leiden and prothrombin G20210A and methyltetrahydrofolate reductase mutations: successful treatment with warfarin.
Clivati Brandt HR; de Lorenzo Messina MC; Belda Júnior W; Costa Martins JE; Criado PR
Int J Dermatol; 2007 Dec; 46(12):1319-20. PubMed ID: 18173539
[No Abstract] [Full Text] [Related]
8. [Livedoid vasculopathy. Pathogenesis, diagnosis and treatment of cutaneous infarction].
Goerge T
Hautarzt; 2011 Aug; 62(8):627-34; quiz 635. PubMed ID: 21786003
[TBL] [Abstract][Full Text] [Related]
9. Livedoid vasculopathy: an intringuing cutaneous disease.
Criado PR; Rivitti EA; Sotto MN; Valente NY; Aoki V; Carvalho JF; Vasconcellos C
An Bras Dermatol; 2011; 86(5):961-77. PubMed ID: 22147037
[TBL] [Abstract][Full Text] [Related]
10. Livedoid vasculopathy and its association with factor V Leiden mutation.
Yong AA; Tan AW; Giam YC; Tang MB
Singapore Med J; 2012 Dec; 53(12):e258-60. PubMed ID: 23268168
[TBL] [Abstract][Full Text] [Related]
11. [Reticulate necrotic lesions on lower legs].
Winter CM; Hehl N; Gethöffer K; Pfeiffer C; Scharffetter-Kochanek K
Hautarzt; 2014 Aug; 65(8):728-31. PubMed ID: 25113332
[No Abstract] [Full Text] [Related]
12. Unilateral livedoid vasculopathy associated with involutional phase of cutaneous infantile hemangioma: the connection to coagulation disorders.
Criado PR; Alavi A; Halpern I; Sotto MN; Kirsner RS
Int J Low Extrem Wounds; 2013 Dec; 12(4):306-9. PubMed ID: 24043683
[TBL] [Abstract][Full Text] [Related]
13. Heterozygous prothrombin gene mutation associated with livedoid vasculopathy.
Anavekar NS; Kelly R
Australas J Dermatol; 2007 May; 48(2):120-3. PubMed ID: 17535202
[TBL] [Abstract][Full Text] [Related]
14. Livedoid vasculopathy - a thrombotic disease.
Kerk N; Goerge T
Vasa; 2013 Sep; 42(5):317-22. PubMed ID: 23989066
[TBL] [Abstract][Full Text] [Related]
15. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) and prothrombin G20210A heterozygosity: response to t-PA therapy.
Antunes J; Filipe P; André M; Fraga A; Miltenyi G; Marques Gomes M
Acta Derm Venereol; 2010; 90(1):91-2. PubMed ID: 20107738
[No Abstract] [Full Text] [Related]
16. Livedoid vasculopathy presenting with leg ulcers.
Kumar A; Sharma A; Agarwal A
Rheumatology (Oxford); 2019 Nov; 58(11):2076. PubMed ID: 31220328
[No Abstract] [Full Text] [Related]
17. Livedoid vasculopathy and hypercoagulability in a patient with primary Sjögren's syndrome.
Cardoso R; Gonçalo M; Tellechea O; Maia R; Borges C; Silva JA; Figueiredo A
Int J Dermatol; 2007 Apr; 46(4):431-4. PubMed ID: 17442092
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Livedoid Vasculopathy With Rivaroxaban: A Potential Use of New Oral Anticoagulants for Dermatologists.
Jiménez-Gallo D; Villegas-Romero I; Rodríguez-Mateos ME; Linares-Barrios M
Actas Dermosifiliogr (Engl Ed); 2018 Apr; 109(3):278-281. PubMed ID: 29074145
[No Abstract] [Full Text] [Related]
19. Case of livedoid vasculopathy with extensive dermal capillary thrombi.
Shimizu A; Tamura A; Yamanaka M; Amano H; Nagai Y; Ishikawa O
J Dermatol; 2010 Jan; 37(1):94-7. PubMed ID: 20175829
[TBL] [Abstract][Full Text] [Related]
20. Livedoid vasculopathy - current aspects of diagnosis and treatment of cutaneous infarction.
Kerk N; Goerge T
J Dtsch Dermatol Ges; 2013 May; 11(5):407-10. PubMed ID: 23437985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
